Tadalafil C20 20 mg/tab 10 pills |

About Tadalafil C20 | HilmaBiocare

Tadalafil (C-20) - Hilma Biocare

Tadalafil is a prescription medication classified as a phosphodiesterase type 5 (PDE5) inhibitor. It is used in clinical practice for erectile dysfunction, benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension (PAH) under professional supervision. Compared with some other PDE5 inhibitors, tadalafil has a longer duration of action due to its pharmacokinetic profile.

General Overview

Class: Phosphodiesterase type 5 (PDE5) inhibitor
Structure: Tadalafil
Context of use: Prescription medical use under professional supervision (ED, BPH, PAH)

Potentially Observed Effects
(based on pharmacological action and clinical use)

Improved erectile function through enhanced blood flow
Vasodilatory effects that may influence peripheral circulation
Longer duration of effect compared with shorter-acting PDE5 inhibitors (individual response varies)

Safety Information

Tadalafil may be associated with side effects and clinically relevant risks. Commonly reported adverse effects include headache, flushing, nasal congestion, dyspepsia, and back or muscle pain. Blood pressure changes can occur, particularly when combined with nitrates or other antihypertensive agents, and in individuals with underlying cardiovascular conditions. Use should always be guided by a qualified medical professional.

Disclaimer: This text is provided for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always comply with the laws of your country and use prescription medicines only under qualified medical supervision.